Sonnet Biotherapeutics, Inc. is a cytokine-derived therapeutic candidates founded in 2015 by Pankaj Mohan.
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action.
Cytokine-derived therapeutic candidates
Cytokine-derived therapeutic candidates
Cytokine-derived therapeutic candidates